Drug Consumption Rooms : Opinion and willingness among people who inject drugs in Marseille, France,Salles de consommation à moindre risque : opinion et volonté d’utilisation des personnes injectrices de substances psychoactives à Marseille, France
Revue d'Épidémiologie et de Santé Publique. 2023-02-01; 71(1): 101421
DOI: 10.1016/j.respe.2022.101421
Lire sur PubMed
Article in French
Briand Madrid L(1), Donadille C(2), Célerier I(3), Gutowski M(3), Grelli N(4), Maradan G(5), Jauffret-Roustide M(6), Lalanne L(7), Auriacombe M(8), Roux P(2); et le groupe de recherche Cosinus.
Author information:
(1)Aix Marseille Université, Inserm, IRD, SESSTIM, Sciences économiques &
sociales de la santé & traitement de l’information médicale, ISSPAM, Marseille,
France. Electronic address: .
(2)Aix Marseille Université, Inserm, IRD, SESSTIM, Sciences économiques &
sociales de la santé & traitement de l’information médicale, ISSPAM, Marseille,
France.
(3)ASUD Mars Say Yeah, Marseille, France.
(4)Nouvelle Aube, Marseille, France.
(5)ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d’Azur,
Marseille, France.
(6)British Columbia Center on Substance Use (BCCSU), Vancouver, Canada; Baldy
Center on Law and Social Policy, Buffalo University, New York, USA; Centre
d’étude des mouvements sociaux, Inserm U1276/CNRS UMR 8044/EHESS, Paris, France.
(7)Inserm 1114, Department of Psychiatry and Addictology, University Hospital of
Strasbourg, Fédération de médecine translationnelle de Strasbourg (FMTS),
67000 Strasbourg, France; Department of Addictology, University Hospital of
Strasbourg, Fédération de médecine translationnelle de Strasbourg (FMTS),
67000 Strasbourg, France.
(8)Bordeaux University, SANPSY, CNRS UMR 6033, Bordeaux, France; Addiction
Clinic (Pôle interétablissement d’addictologie), CHU Bordeaux and CH Charles
Perrens, Bordeaux, France.
BACKGROUND: In France, people who inject drugs (PWID) are still one of the most
at risk population for contracting hepatitis C virus (HCV). Drug consumption
rooms (DCR) have shown their effectiveness on HCV risk behaviors abroad and in
France, where they have been recently evaluated with the COSINUS study. In
France, two DCRs opened in 2016, one in Paris and another in Strasbourg. The
objective of this sub-analysis was to explore the willingness to use a DCR in
PWID living in Marseille, where no DCR is opened.
METHODS: The COSINUS study is a prospective multicenter cohort that included 665
PWID recruited in Bordeaux, Marseille, Paris and Strasbourg between 2016 and
2019. Investigators administered questionnaires face-to-face at regular
intervals at baseline, 3 months, 6 months and 12 months. In Marseille, 199 PWID
were recruited. A multivariable logistic regression model was performed to
assess factors associated with willingness to use DCR among this population.
RESULTS: Among 545 observations corresponding to 195 distinct participants
selected for analyses, 57% declared they were willing to attend a DCR. The main
reason given was « to consume more cleanly ». Receiving allowances (OR = 2.38; 95%
confidence interval (CI) (95% CI) = 1.17-4.81), not having health insurance (OR
= 3.61; 95% CI = 1.49-8.75), injecting daily (OR = 1.97; 95% CI = 1.05-3.70) and
in a public space (OR = 2.66; 95% CI = 1.29-5.47) were all positively associated
with willingness to use a DCR.
CONCLUSIONS: DCR are devices that target PWID exposed to high sanitary or social
risks, i.e. people living in precarious conditions, who have to inject in public
spaces, in deleterious sanitary environments and with rapid gestures in order
not to be seen. These analyzes highlight that the people who most want to attend
a DCR are aware of the harms associated with their practices and show a desire
to seek protection from street-based drug scenes.
Copyright © 2022. Published by Elsevier Masson SAS.